Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
Initial results show excellent immune response after third dose of VLA2001 administered 7 to 8 months after the second dose of primary vaccinationAntibody titers increased 42- to 106-fold two... | December 16, 2021
Source: marketscreener.com